https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 02:13:212024-03-18 10:38:12Gut microbiota signature in Duchenne Muscular Dystrophy
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 02:11:532024-03-18 10:38:24Clinical and genetic features of a cohort of patients with myoadenilate deaminase deficiency: a new mutation
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 02:10:402024-03-18 10:38:24Neurofilament light chain as clinical plasma biomarker of Charcot-Marie-Tooth disease
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 02:09:252024-03-18 10:38:25Steroid-sparing effect of Eculizumab therapy in patients with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 02:05:192024-03-18 10:38:25SMN circ4-2b-3 is expressed in nusinersen treated SMA I children and correlates with motor outcomes
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 01:54:382024-03-18 10:38:25Cardiac risk and myocardial fibrosis assessment with Cardiac Magnetic Resonance in patients with Myotonic Dystrophy
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 01:51:412024-03-18 10:38:25Efgartigimod in non-AChR generalized myasthenia gravis
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 01:28:022024-03-18 10:38:25Switching treatment to cipaglucosidase alfa plus miglustat positively affects motor function and quality of life in patients with late-onset Pompe disease
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 01:24:252024-03-18 10:38:25Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome?
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-15 01:21:102024-03-18 10:38:25Extensive next-generation sequencing approaches for the identification of rare genomic structural variants involving the DMD gene
